MILOOP LENS FRAGMENTATION DEVICE FG-11881

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2019-03-26 for MILOOP LENS FRAGMENTATION DEVICE FG-11881 manufactured by Carl Zeiss Meditec Cataract Technology, Inc..

Event Text Entries

[139877635] The device was discarded by the user facility and is not available for evaluation. The device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event. Based on the information reviewed, there is no evidence to indicate the presence of a potential quality issue with respect to manufacturing, design, or labeling. The primary cause of the zonular tear was attributed to the patient's preexisting conditions (e. G. , dense cataract, weak zonules, and pseudoexfoliation, etc. ). The surgeon stated that it was likely that the weak zonules would not have survived any other surgical technique to remove the nucleus, including small incision cataract surgery, extracapsular cataract extraction, or phacoemulsification. Zonular dehiscence is an inherent risk of cataract surgery. Manufacturer's reference #: (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[139877636] A (b)(6) year-old monocular patient with a very dense brunescent grade 4+ nuclear sclerotic cataract, pseudoexfoliation, and weak zonules underwent cataract surgery on (b)(6) 2019 where the miloop device was used in an attempt to section the cataractous lens into quadrants. The patient had a complex ocular history in the operative eye that included end-stage glaucoma, advanced macular degeneration, and limited light perception vision (in addition to the dense cataract, pseudoexfoliation, and weak zonules). Given the medical history, the surgeon's goal for cataract surgery was to try to achieve ambulatory vision. The surgeon reports he was hoping to use the miloop to section the nucleus to make phacoemulsification easier; however, he experienced difficulty capturing the nucleus due its very large size. When the nucleus tipped during manipulation, it became apparent that the zonules had torn. The procedure was subsequently aborted and the patient was referred to a retina specialist who performed surgery approximately 45 minutes later. No intraocular lens (iol) was implanted and the patient is being fitted for aphakic spectacles (no iol implantation is planned). The patient's prognosis is good. At the one day postoperative visit, the patient's bcva improved to count fingers in the periphery and the patient was happy with this improvement.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3012123033-2019-00002
MDR Report Key8452666
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2019-03-26
Date of Report2019-03-26
Date of Event2019-02-28
Date Mfgr Received2019-02-28
Device Manufacturer Date2018-05-03
Date Added to Maude2019-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJANE DEMKOVICH
Manufacturer Street8748 TECHNOLOGY WAY
Manufacturer CityRENO NV 89521
Manufacturer CountryUS
Manufacturer Postal89521
Manufacturer Phone7754731014
Manufacturer G1CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
Manufacturer Street8748 TECHNOLOGY WAY
Manufacturer CityRENO NV 89521
Manufacturer CountryUS
Manufacturer Postal Code89521
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMILOOP LENS FRAGMENTATION DEVICE
Generic NameOPHTHALMIC HOOK
Product CodeHNQ
Date Received2019-03-26
Model NumberFG-11881
Lot NumberFG20180502-20
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
Manufacturer Address8748 TECHNOLOGY WAY RENO NV 89521 US 89521


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2019-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.